Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Droperidol

A neuroleptic of the butyrophenone family discovered in Belgium in 1961: it is used at low doses to prevent nausea and vomiting after surgery and for rapid sedation in acute agitation. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Paired with the opioid fentanyl it is the classic example of neuroleptanalgesia, an anaesthetic technique widely used from the 1960s that induces a calm, detached and pain-free state.

DroperidolGo to the active ingredient →
DroperidolActive ingredientDroperidolCat. No. P-D189-001CAS 548-73-2

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Reference substanceDroperidol CRSEDQM code D3100000Family Droperidol

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.